Effect of adjuvant-induced systemic inflammation in rats on hepatic disposition kinetics of taurocholate

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 300, Issue 1, 2011, Pages

  Roberts, Michael S ^a,c   Liu, Xin ^a   Zou, Yuhong ^a   Siebert, Gerhard A ^a   Chang, Ping ^a   Whitehouse, Michael W ^a   Fletcher, Linda ^b   Crawford, Darrell H G ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Bile salt transporter; Hepatic extraction; Systemic inflammation

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADJUVANT; BILE SALT; BILE SALT TRANSPORTER; MESSENGER RNA; TAUROCHOLIC ACID; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DILUTION; DRUG DISPOSITION; DRUG ELIMINATION; DRUG EXCRETION; DRUG ISOLATION; DRUG TRANSPORT; FEMALE; LIVER; LIVER DISEASE; LIVER METABOLISM; LIVER PERFUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADENOSINE TRIPHOSPHATE; ANIMALS; FEMALE; GLUTATHIONE TRANSFERASE; HEPATOCYTES; INFLAMMATION; LIVER; MYCOBACTERIUM BOVIS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TAUROCHOLIC ACID;

EID: 78650789830     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00162.2010     Document Type: Article

References (39)

1. Akita H, Suzuki H, Ito K, Kinoshita S, Sato N, Takikawa H, Sugiyama Y. Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump. Biochim Biophys Acta 1511: 7-16, 2001.
2. Alin P, Mannervik B, Jornvall H. Structural evidence for three different types of glutathione transferase in human tissues. FEBS Lett 182: 319-322, 1985. (Pubitemid 15074360)
3. Bohan A, Chen WS, Denson LA, Held MA, Boyer JL. Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis. J Biol Chem 278: 36688-36698, 2003.
4. Brahn E. Animal models of rheumatoid arthritis. Clues to etiology and treatment. Clin Orthop Related Res: 42-53, 1991.
5. Brinkman-van der Linden EC, van Ommen EC, van Dijk W. Glycosylation of alpha 1-acid glycoprotein in septic shock: changes in degree of branching and in expression of sialyl Lewis(x) groups. Glycoconj J 13: 27-31, 1996.
6. Cherrington NJ, Slitt AL, Li N, Klaassen CD. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab Dispos 32: 734-741, 2004.
7. Cheung K, Hickman PE, Potter JM, Walker NI, Jericho M, Haslam R, Roberts MS. An optimized model for rat liver perfusion studies. J Surg Res 66: 81-89, 1996.
8. Evdokimova E, Taper H, Buc Calderon P. Role of ATP and glycogen reserves in both paracetamol sulfation and glucuronidation by cultured precision-cut rat liver slices. Toxicol In Vitro 15: 683-690, 2001.
9. Geier A, Wagner M, Dietrich CG, Trauner M. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim Biophys Acta 1773: 283-308, 2007.
10. Goralski KB, Hartmann G, Piquette-Miller M, Renton KW. Down-regulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br J Pharmacol 139: 35-48, 2003.
11. Green RM, Beier D, Gollan JL. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 111: 193-198, 1996.
12. Green RM, Gollan JL, Hagenbuch B, Meier PJ, Beier DR. Regulation of hepatocyte bile salt transporters during hepatic regeneration. Am J Physiol Gastrointest Liver Physiol 273: G621-G627, 1997. (Pubitemid 27418781)
13. Guirguis MS, Jamali F. Disease-drug interaction: Reduced response to propranolol despite increased concentration in the rat with inflammation. J Pharm Sci 92: 1077-1084, 2003.
14. Horie Y, Kato S, Ohki E, Tamai H, Yamagishi Y, Ishii H. Hepatic microvascular dysfunction in endotoxemic rats after acute ethanol administration. Alcohol Clin Exp Res 24: 691-698, 2000. (Pubitemid 30337765)
15. Hung DY, Chang P, Cheung K, McWhinney B, Masci PP, Weiss M, Roberts MS. Cationic drug pharmacokinetics in diseased livers determined by fibrosis index, hepatic protein content, microsomal activity, and nature of drug. J Pharmacol Exp Ther 301: 1079-1087, 2002.
16. Hung DY, Chang P, Weiss M, Roberts MS. Structure-hepatic disposition relationships for cationic drugs in isolated perfused rat livers: transmembrane exchange and cytoplasmic binding process. J Pharmacol Exp Ther 297: 780-789, 2001.
17. Hung DY, Siebert GA, Chang P, Roberts MS. Hepatic pharmacokinetics of taurocholate in the normal and cholestatic rat liver. Br J Pharmacol 145: 57-65, 2005.
18. Hung DY, Siebert GA, Chang P, Whitehouse MW, Fletcher L, Crawford DH, Roberts MS. Hepatic pharmacokinetics of propranolol in rats with adjuvant-induced systemic inflammation. Am J Physiol Gastrointest Liver Physiol 290: G343-G351, 2006.
19. Kullak-Ublick GA, Beuers U, Paumgartner G. Hepatobiliary transport. J Hepatol 32: 3-18, 2000.
20. Kulmatycki KM, Abouchehade K, Sattari S, Jamali F. Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat. Br J Pharmacol 133: 286-294, 2001.
21. Le Vee M, Lecureur V, Stieger B, Fardel O. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug Metab Dispos 37: 685-693, 2009.
22. Liu X, Rusch NJ, Striessnig J, Sarna SK. Down-regulation of L-type calcium channels in inflamed circular smooth muscle cells of the canine colon. Gastroenterology 120: 480-489, 2001.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
24. Lukita-Atmadja W, Ito Y, Baker GL, McCuskey RS. Effect of curcuminoids as anti-inflammatory agents on the hepatic microvascular response to endotoxin. Shock 17: 399-403, 2002.
25. Meier PJ, Stieger B. Bile salt transporters. Annu Rev Physiol 64: 635-661, 2002.
26. Piquette-Miller M, Pak A, Kim H, Anari R, Shahzamani A. Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation. Pharm Res 15: 706-711, 1998.
27. Poon PY, Whitehouse MW. Pathobiodynamics: changes in ascorbate metabolism in rats with peripheral inflammation. Biochem Med 20: 81-86, 1978.
28. Purves RD. Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC). J Pharmacokinet Biopharm 20: 211-226, 1992.
29. Roberts MS, Anissimov YG. Modeling of hepatic elimination and organ distribution kinetics with the extended convection-dispersion model. J Pharmacokinet Biopharm 27: 343-382, 1999.
30. Roelofsen H, Schoemaker B, Bakker C, Ottenhoff R, Jansen PL, Elferink RP. Impaired hepatocanalicular organic anion transport in endotoxemic rats. Am J Physiol Gastrointest Liver Physiol 269: G427-G434, 1995.
31. Rycroft BK, Vikman KS, Christie MJ. Inflammation reduces the contribution of N-type calcium channels to primary afferent synaptic transmission onto NK1 receptor-positive lamina I neurons in the rat dorsal horn. J Physiol 580: 883-894, 2007.
32. Siebert GA, Hung DY, Chang P, Roberts MS. Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs. J Pharmacol Exp Ther 308: 228-235, 2004.
33. Trauner M, Arrese M, Lee H, Boyer JL, Karpen SJ. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest 101: 2092-2100, 1998.
34. Unger LS, Cryer HM, Garrison RN. Differential response of the microvasculature in the liver during bacteremia. Circ Shock 29: 335-344, 1989.
35. Van Eden W, Wagenaar-Hilbers JP, Wauben MH. Adjuvant arthritis in the rat. In: Curr Protoc Immunol 15: unit 15.4, 2001.
36. Vos TA, Hooiveld GJ, Koning H, Childs S, Meijer DK, Moshage H, Jansen PL, Muller M. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 28: 1637-1644, 1998.
37. Walters HC, Craddock AL, Fusegawa H, Willingham MC, Dawson PA. Expression, transport properties, and chromosomal location of organic anion transporter subtype 3. Am J Physiol Gastrointest Liver Physiol 279: G1188-G1200, 2000.
38. Whitehouse MW, Beck FJ. Impaired drug metabolism in rats with adjuvant-induced arthritis: a brief review. Drug Metab Dispos 1: 251-255, 1973.
39. Whiting JF, Green RM, Rosenbluth AB, Gollan JL. Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis. Hepatology 22: 1273-1278, 1995.